Mdxhealth to Release Third Quarter 2026 Financial Results on November 12
Company to Host Conference Call with Live Q&A, November 12, 2026, at 4:30pm ET / 22:30 CET
IRVINE, California – October 29, 2026 (GlobeNewswire) – Mdxhealth SA (NASDAQ: MDXH), a leading precision diagnostics company, today announced it will release its financial results for the third quarter ended September 30, 2026, after market close on Thursday, November 12, 2026.
| Title: | Mdxhealth Presents Third Quarter 2026 Financial Results and Corporate Update Conference Call and Webcast |
| Date: | November 12, 2026 |
| Time: | 4:30pm ET/ 22:30 CET |
| Conference Call Dial-in Details: | United States: 1-800-347-6865 Belgium: 08 007 2519 United Kingdom: 0808 101 1183 |
| Conference ID: | MDX3Q26 |
| Webcast: | https://viavid.webcasts.com/starthere.jsp?ei=1778654&tp_key=d6263296bf |
The webcast should be accessed 15 minutes prior to the conference call start time. A replay of the webcast will be available following the conclusion of the live call and will be accessible on the Company’s website.
About Mdxhealth
Mdxhealth is a leading precision diagnostics company that provides actionable molecular information to personalize patient diagnosis and treatment. The Company’s tests, based on proprietary genomic, epigenomic, exosomal and other molecular technologies, assist physicians with the diagnosis and prognosis of prostate cancer and other urologic diseases. For more information, visit mdxhealth.com and follow us on social media at: twitter.com/mdxhealth, facebook.com/mdxhealth and linkedin.com/company/mdxhealth.
For more information:
LifeSci Advisors (IR & PR)
John Fraunces, Managing Director
Tel: +1 917 355 2395
jfraunces@lifesciadvisors.com
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
These Overvalued Stocks Have Plenty of Room to Fall
Your Year-End Financial Checklist: 5 Things to Tackle Before 2027
4 Big Impacts From the US Midterm Elections for Investors
The 10 Best Companies to Invest in Now
United States